Clinical Trial Update: Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Thiotepa-Clofarabine-Busulfan conditioning with allogeneic stem cell transplant for high-risk malignancies has completed; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Stem Cell Transplantation

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stem Cell Transplantation, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-04-07